Healthcare · Drug Manufacturers General · NYSE
| Market cap | $127.16B |
|---|---|
| Trailing P/E | 9.6 |
| FCF yield | 10.1% |
| Revenue growth (YoY) | -0.2% |
| EPS growth (YoY) | +439.5% |
| FCF/share growth (YoY) | -8.4% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Bristol-Myers Squibb Company trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Thomas H Tuberville | Senate | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Mike Kelly | House | Sell | $15,001 - $50,000 | Jun 11, 2026 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | Jan 15, 2026 |
| Julia Letlow | House | Sell | $1,001 - $15,000 | Jan 13, 2026 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Jan 13, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Jan 12, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Dec 15, 2025 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | Dec 11, 2025 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Nov 18, 2025 |